Sujana Movva

Also affiliated with Cornell University, Kettering University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab”.

Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

JAMA Oncology(2020)10.1001/jamaoncol.2019.6152

N/A

5.0DataRank · unranked

207 citations

Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson +21 more

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1824

N/A

0.807DataRank · unranked

216 citations

Melissa Burgess, Ruth Salazar, Edwin R. Parra, Jaime Rodrigues-Canales, Vanessa Bolejack +18 more

Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3909

N/A

0.627DataRank · unranked

16 citations

Li‐Xuan Qin, Niedzica Camacho, Ciara M. Kelly, Sandra P. D’Angelo, Mark A. Dickson +19 more

HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0832

N/A

0.494DataRank · unranked

26 citations

Kenneth Seier, Chaitanya Bandlamudi, Mark A. Dickson, Mrinal M. Gounder, Mary Lou Keohan +12 more

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2145

N/A

0.416DataRank · unranked

15 citations

Naoko Takebe, Shivaani Kummar, Albiruni R. Abdul Razak, Sant P. Chawla, Suzanne George +13 more

Analysis of survival data with nonproportional hazards: A comparison of propensity‐score‐weighted methods

Biometrical Journal(2022)10.1002/bimj.202200099

N/A

0.287DataRank · unranked

4 citations

Marc C. Smaldone, Sujana Movva, Nandita Mitra, Elizabeth A. Handorf

Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0140

N/A

0DataRank · unranked

11 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11590

N/A

0DataRank · unranked

3 citations

Evan Rosenbaum, Rodrigo Gularte Mérida, Mark A. Dickson, Mary Louise Keohan, Mrinal M. Gounder +15 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242.v1

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Data from Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

(2023)10.1158/2767-9764.c.6886242

N/A

0DataRank · unranked

0 citations

Kenneth Seier, Martina Bradić, Ciara M. Kelly, Sujana Movva, Benjamin A. Nacev +12 more

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2519

N/A

0DataRank · unranked

20 citations

Kenneth Seier, Viswatej Avutu, Lauren B. Banks, Jason E. Chan, Ping Chi +20 more

Data from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

(2024)10.1158/1078-0432.c.7077823.v1

N/A

0DataRank · unranked

0 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more

1762P Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1853

N/A

0DataRank · unranked

0 citations

Martina Bradić, Sara Saunds, V. Avutu, Jason W. Chan, Sandra P. D’Angelo +15 more

Association of early dexrazoxane with reduced cardiotoxicity risk in sarcoma patients treated with anthracycline chemotherapy

The Oncologist(2025)10.1093/oncolo/oyaf370

N/A

0DataRank · unranked

2 citations

Joseph S. Wallins, I‐Hsin Lin, Sujana Movva, William D. Tap, Jennifer E Liu +2 more

High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012357

N/A

0DataRank · unranked

1 citations

Martina Bradić, Hyung Jun Woo, Allison L. Richards, Ciara M. Kelly, Mark A. Dickson +17 more

SAR-096: A phase II trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11544

N/A

0DataRank · unranked

13 citations

Margaret von Mehren, Elizabeth A. Handorf, Jeffrey A. Morgan, Michael J. Nathenson, Katherine A. Thornton +10 more

Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

Nature Communications(2022)10.1038/s41467-022-30453-x

N/A

0DataRank · unranked

215 citations

Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi +42 more

Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004149

N/A

0DataRank · unranked

58 citations

Cristina R. Antonescu, Shaleigh Smith, Martina Bradić, Daniel Kashani, Allison L. Richards +17 more

A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3911

N/A

0DataRank · unranked

69 citations

Li‐Xuan Qin, Karissa Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan +18 more

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2378

N/A

0DataRank · unranked

36 citations

Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu, Rodrigo Gularte‐Mérida, Marimar Benitez +31 more